Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -985.20% is 217% below its 5-year average of -310.43%, around the middle of its 5-year range (-3112.98%–-24.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.86% above its 12-month average of -1199.37%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -985.20%.
RETURN ON INVESTED CAPITAL (ROIC)
-985.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1199.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-722.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-310.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-352.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-231.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-170.68%
CURRENT VS TTM AVG
+17.86%
CURRENT VS 3Y AVG
-36.44%
CURRENT VS 5Y AVG
-217.36%
CURRENT VS 10Y AVG
-179.41%
CURRENT VS 15Y AVG
-326.08%
CURRENT VS 20Y AVG
-477.21%
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
-2851.01%
vs the sector median at left
GeoVax Labs, Inc.
Market Cap
$2.22M
Return on Invested Capital (ROIC)
-985.20%
TTM Avg
-1199.37%
3Y Avg
-722.06%
5Y Avg
-310.43%
Market Cap
$2.32M
Return on Invested Capital (ROIC)
-71.90%
TTM Avg
-86.03%
3Y Avg
-72.74%
5Y Avg
-64.31%
Market Cap
$2.33M
Return on Invested Capital (ROIC)
-58.05%
TTM Avg
-445.82%
3Y Avg
-256.67%
5Y Avg
-256.67%
Market Cap
$2.37M
Return on Invested Capital (ROIC)
-59.84%
TTM Avg
-167.05%
3Y Avg
-109.85%
5Y Avg
-118.30%
Market Cap
$2.43M
Return on Invested Capital (ROIC)
-242.25%
TTM Avg
-196.63%
3Y Avg
-136.47%
5Y Avg
-108.21%
Market Cap
$2.45M
Return on Invested Capital (ROIC)
-286.46%
TTM Avg
-159.21%
3Y Avg
-198.72%
5Y Avg
-198.72%
Market Cap
$1.93M
Return on Invested Capital (ROIC)
-518.15%
TTM Avg
-216.02%
3Y Avg
-220.11%
5Y Avg
-314.84%
Market Cap
$2.51M
Return on Invested Capital (ROIC)
-237.93%
TTM Avg
-187.67%
3Y Avg
-136.08%
5Y Avg
-136.08%
Market Cap
$2.56M
Return on Invested Capital (ROIC)
-110.81%
TTM Avg
-123.52%
3Y Avg
-108.42%
5Y Avg
-102.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | $2.22M | -985.20% | -1199.37% | -722.06% | -310.43% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | -71.90% | -86.03% | -72.74% | -64.31% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.33M | -58.05% | -445.82% | -256.67% | -256.67% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -59.84% | -167.05% | -109.85% | -118.30% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.43M | -242.25% | -196.63% | -136.47% | -108.21% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.45M | -286.46% | -159.21% | -198.72% | -198.72% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.93M | -518.15% | -216.02% | -220.11% | -314.84% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.51M | -237.93% | -187.67% | -136.08% | -136.08% |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | -110.81% | -123.52% | -108.42% | -102.13% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.84M | -23.73% | -180.49% | -523.36% | -372.55% |
ROIC
-985.2%
ROE
-1160.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -985.20% |
| 2026-03-31 | -3112.98% |
| 2025-12-31 | -491.22% |
| 2025-09-30 | -520.51% |
| 2025-06-30 | -886.97% |
| 2025-03-31 | -312.31% |
| 2024-12-31 | -498.05% |
| 2024-09-30 | -288.03% |
| 2023-12-31 | -464.02% |
| 2023-09-30 | -267.97% |
| 2023-06-30 | -115.40% |
| 2023-03-31 | -69.41% |
| 2022-12-31 | -52.74% |
| 2022-09-30 | -66.26% |
| 2022-06-30 | -68.17% |
| 2022-03-31 | -146.85% |
| 2021-12-31 | -294.67% |
| 2021-09-30 | -35.21% |
| 2021-06-30 | -24.79% |
| 2021-03-31 | -18.16% |
| 2020-12-31 | -28.84% |
| 2020-09-30 | -18.80% |
| 2017-06-30 | -729.69% |
| 2016-12-31 | -1361.84% |
| 2016-09-30 | -717.31% |
| 2016-06-30 | -2006.72% |
| 2016-03-31 | -522.19% |
| 2015-12-31 | -223.68% |
| 2015-09-30 | -155.59% |
| 2015-06-30 | -113.55% |
| 2015-03-31 | -89.80% |
| 2014-12-31 | -238.85% |
| 2014-09-30 | -304.23% |
| 2014-06-30 | -184.09% |
| 2014-03-31 | -114.00% |
| 2013-12-31 | -90.59% |
| 2013-09-30 | -116.81% |
| 2013-06-30 | -112.76% |
| 2013-03-31 | -118.30% |
| 2012-12-31 | -185.85% |
| 2012-09-30 | -157.91% |
| 2012-06-30 | -144.49% |
| 2012-03-31 | -106.27% |
| 2011-12-31 | -333.86% |
| 2011-09-30 | -144.24% |
| 2011-06-30 | -138.90% |
| 2011-03-31 | -192.01% |
| 2010-12-31 | -150.90% |
| 2010-09-30 | -146.44% |
| 2010-06-30 | -104.01% |
| 2010-03-31 | -93.51% |
| 2009-12-31 | -88.55% |
| 2009-09-30 | -89.53% |
| 2009-06-30 | -191.40% |
| 2009-03-31 | -159.99% |
| 2008-12-31 | -140.28% |
| 2008-09-30 | -117.15% |
| 2008-06-30 | -118.89% |
| 2008-03-31 | -183.96% |
| 2007-12-31 | -162.56% |
| 2007-09-30 | -1075.36% |
| 2007-06-30 | -291.19% |
| 2007-03-31 | -38.83% |
| 2006-12-31 | -48.14% |
| 2006-09-30 | -34.27% |
| 2002-12-31 | 48.58% |
| 2002-09-30 | -975.75% |
| 2002-06-30 | -777.60% |
